https://endpoints.news/dna-chopping-enzyme-that-breaks-up-nets-may-offer-new-way-to-fight-autoimmune-disease-early-data-from-neutrolis-suggest/
0
0
46 words
0
Comments
Neutrolis tests enzyme therapy targeting neutrophil extracellular traps (NETs) in Phase 1 trial, showing promise for autoimmune diseases. Drug cleared symptoms in teen with DNASE1L3 deficiency.
You are the first to view
Create an account or login to join the discussion